![]() |
Name |
Penicisulfuranol F
|
Molecular Formula | C22H26N2O8S2 | |
IUPAC Name* |
(2R,3R,6'aS,7'R,10'R,10'aS,11'aR)-7',10',10'a-trihydroxy-7-methoxy-2'-methyl-3,11'a-bis(methylsulfanyl)spiro[3H-1-benzofuran-2,3'-6a,7,10,11-tetrahydropyrazino[1,2-b][1,2]benzoxazine]-1',4'-dione
|
|
SMILES |
CN1C(=O)[C@@]2(C[C@@]3([C@@H](C=C[C@H]([C@@H]3ON2C(=O)[C@@]14[C@@H](C5=C(O4)C(=CC=C5)OC)SC)O)O)O)SC
|
|
InChI |
InChI=1S/C22H26N2O8S2/c1-23-18(27)21(34-4)10-20(29)14(26)9-8-12(25)16(20)32-24(21)19(28)22(23)17(33-3)11-6-5-7-13(30-2)15(11)31-22/h5-9,12,14,16-17,25-26,29H,10H2,1-4H3/t12-,14-,16+,17-,20+,21-,22+/m1/s1
|
|
InChIKey |
BBMMLEPSNGCFAM-PQJPUEHUSA-N
|
|
Synonyms |
Penicisulfuranol F; CHEMBL4097656
|
|
CAS | NA | |
PubChem CID | 137660398 | |
ChEMBL ID | CHEMBL4097656 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 510.6 | ALogp: | -0.1 |
HBD: | 3 | HBA: | 10 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 180.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 34 | QED Weighted: | 0.499 |
Caco-2 Permeability: | -5.497 | MDCK Permeability: | 0.00000852 |
Pgp-inhibitor: | 0.979 | Pgp-substrate: | 0.987 |
Human Intestinal Absorption (HIA): | 0.939 | 20% Bioavailability (F20%): | 0.933 |
30% Bioavailability (F30%): | 0.971 |
Blood-Brain-Barrier Penetration (BBB): | 0.211 | Plasma Protein Binding (PPB): | 86.78% |
Volume Distribution (VD): | 1.048 | Fu: | 9.52% |
CYP1A2-inhibitor: | 0.014 | CYP1A2-substrate: | 0.867 |
CYP2C19-inhibitor: | 0.039 | CYP2C19-substrate: | 0.889 |
CYP2C9-inhibitor: | 0.184 | CYP2C9-substrate: | 0.089 |
CYP2D6-inhibitor: | 0 | CYP2D6-substrate: | 0.079 |
CYP3A4-inhibitor: | 0.499 | CYP3A4-substrate: | 0.95 |
Clearance (CL): | 3.337 | Half-life (T1/2): | 0.785 |
hERG Blockers: | 0.001 | Human Hepatotoxicity (H-HT): | 0.238 |
Drug-inuced Liver Injury (DILI): | 0.966 | AMES Toxicity: | 0.206 |
Rat Oral Acute Toxicity: | 0.733 | Maximum Recommended Daily Dose: | 0.042 |
Skin Sensitization: | 0.325 | Carcinogencity: | 0.89 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.006 |
Respiratory Toxicity: | 0.024 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003539 | ![]() |
0.819 | D03DIG | ![]() |
0.300 | ||
ENC003546 | ![]() |
0.721 | D0WE3O | ![]() |
0.244 | ||
ENC003545 | ![]() |
0.571 | D03SKD | ![]() |
0.234 | ||
ENC003595 | ![]() |
0.558 | D0R9VR | ![]() |
0.234 | ||
ENC003540 | ![]() |
0.557 | D01XWG | ![]() |
0.233 | ||
ENC003738 | ![]() |
0.529 | D0T6RC | ![]() |
0.228 | ||
ENC004277 | ![]() |
0.500 | D06TQZ | ![]() |
0.226 | ||
ENC003544 | ![]() |
0.496 | D07VLY | ![]() |
0.221 | ||
ENC004039 | ![]() |
0.421 | D0C9XJ | ![]() |
0.221 | ||
ENC003659 | ![]() |
0.415 | D0X5KF | ![]() |
0.219 |